Dr. Dino PratoEnvita Medical Centers · Founder and CEO at Envita Medical Centers

What if most chemotherapy never actually reaches the tumor? #shorts

16 Feb 2026 · 1 min

Watch on YouTube

0:38

In this short monologue, the speaker highlights that conventional chemotherapy delivers only about 2–5% of the drug to the tumor, leaving the majority to cause systemic toxicity and immune suppression. He then proposes a radically different approach: using minimally invasive surgery to deliver an immune‑centric therapy directly to the tumor site, achieving 95–100% localized drug delivery. This targeted method is presented as a way to convert "cold" (immune‑invisible) tumors into "hot" tumors that can be recognized and attacked by the body's immune system, thereby reducing side effects and improving cancer treatment efficacy.

Chapters

With most chemo, only a tiny fraction like 2 to 5% ever actually reach the tumor. That means the rest of the 95% is going to harm organs and to destroy the immune system as well. What if we could flip the entire game? Go so much smarter and deeper, direct to the tumor without the same toxicity and with a targeted immunotherapy using minimally invasive type of surgery. What if we could send an immune centric medicine that creates an immunosystem response of the body straight to the tumor? Now we have 95 to 100% of the medicine getting right where we want it and where we need it. Turning cold tumors that are invisible hot so the immune system can fight the cancer.